Quanil en es it fr

Quanil Brand names, Quanil Analogs

Quanil Brand Names Mixture

  • No information avaliable

Quanil Chemical_Formula


Quanil RX_link

No information avaliable

Quanil fda sheet

Quanil msds (material safety sheet)

Quanil Synthesis Reference

No information avaliable

Quanil Molecular Weight

309.469 g/mol

Quanil Melting Point

< 25 oC

Quanil H2O Solubility

Soluble as HCl salt

Quanil State


Quanil LogP


Quanil Dosage Forms

Tablets (oral, 1 mg)

Quanil Indication

Used for the symptomatic treatment of parkinsonism.

Quanil Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Quanil Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Quanil side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Quanil Patient Information

Quanil Organisms Affected

Humans and other mammals